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Background: Obesity amongst children is a growing problem worldwide. In contrast to adults, little is known on
the effects of controlled weight loss on components of the metabolic syndrome in children. The primary aim of the
study was to evaluate the effects of a 20-week exercise and diet guidance intervention on body mass index (BMI) in
a group of overweight children. Our hypothesis was an observed reduction in BMI and secondarily in body fat
content, insulin insensitivity, and other components of the metabolic syndrome in the intervention group.
Methods: School children from Copenhagen were randomly allocated to an intervention group (n = 19) or a
control group (n = 19). Anthropometric assessment, whole body dual-energy X-ray absorptiometry scan, two hours
oral glucose tolerance test, steps measured by pedometer, and fitness tests were measured at baseline and at
20 weeks.
Results: Thirty-seven children (30 girls) participated at baseline, aged 8.7 ± 0.9 years with a BMI of 21.8 ± 3.7 kg/m2
(mean ± SD), and 36 children completed the study. The intervention group decreased their BMI (the intervention
effect is the difference in change between the groups adjusted for the respective baseline values (DELTA) = −2.0 kg/m2,
95% CI: −2.5; −1.5, P <0.001), total body mass (DELTA = −4.0 kg, 95% CI: −4.9; −3.0, P <0.001), and fat mass
(DELTA = −3.3 kg, 95% CI: −4.2; −2.7, P <0.001) compared to the control group after the intervention. The intervention
group displayed decreased waist, hip and waist-to-height ratio (WHtR) (all three variables; P <0.001), area under curve
for plasma insulin (P <0.05), and increased mean and minimum steps/day (P <0.05 and P <0.01, respectively).
Conclusions: The multicomponent intervention had significant favorable effects on BMI, weight, WHtR, mean and
minimum steps/day, and fat mass. In addition, similar beneficial metabolic effects were found in the children as shown
in adults, e.g. increase in peripheral insulin sensitivity.
Trial registration: Clinicaltrials.gov Identifier number NCT01660789.
Keywords: Overweight children, Obesity, Randomized controlled trial, Multicomponent intervention, Physical activity,
Diet counseling, Body mass index, Blood glucose, Insulin, Insulin resistance* Correspondence: Nina.Majlund.Harder@regionh.dk
1Department of Infectious Diseases The Centre of Inflammation and
Metabolism and the Centre for Physical Activity Research, Rigshospitalet, the
Faculty of Health and Medical Sciences, University of Copenhagen,
Copenhagen, Denmark
Full list of author information is available at the end of the article
© 2014 Harder-Lauridsen et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Harder-Lauridsen et al. BMC Pediatrics 2014, 14:273 Page 2 of 14
http://www.biomedcentral.com/1471-2431/14/273Background
Overweight and obesity in children is a growing prob-
lem, and 170 million children below the age of 18 years
globally are estimated to be overweight [1]. In adults,
the combination of obesity and inactivity yields higher
risks of a range of diseases, e.g. type 2 diabetes, certain
types of cancer and cardiovascular diseases [2-4]. Physical
inactivity and low physical fitness are associated with high
abdominal fat, obesity, insulin resistance, and elevated
blood lipid levels in children [5,6] which contribute to the
increasing prevalence of the metabolic syndrome [7-10].
There is an association between overweight in children
and some of the risk factors of the metabolic syndrome
[11], and a positive effect on these risk factors by physical
activity [8]. In addition, energy intake has increased rap-
idly since the 1950s [12], and socio-economic status of the
parents, parental overweight, and higher birth weight are all
also associated with overweight children [13]. Overweight
and obese children are furthermore at risk of a poor quality
of life and early stigmatization with lower self-esteem,
greater shame and perceived teasing compared with their
non-overweight peers [14]. Hence, childhood obesity and
inactivity are considered among the most serious threats
to public health in the 21st century [2,14]. Alarmingly,
over 60% of the children who are overweight before pu-
berty will also be overweight in early adulthood [15,16].
Thus obesity needs to be addressed from an early age.
The few well-designed randomized controlled trials
(RCT) on the reversal of overweight in childhood have
proven most effective when targeting multiple risk behaviors
(with focus on physical activity, diet and behavior change)
[17,18]. However, most have been conducted in the
clinic and are labor intensive. Additional well-designed
community-based studies are required with a strong
family-based component included [17]. The multifactorial
interventions must be cost-effective, feasible, and engaging
for both children and their parents and furthermore, to
reach long-term results, the intervention should include
ongoing support from society as a whole, as well as family,
school and government agencies [19].
The main purpose of the study was to evaluate a multi-
component intervention with a focus on diet and physical
activity on a group of overweight children. The intervention
was chosen based on the following criteria: 1) low-cost, 2)
feasibility (with only two training sessions per week in a
non-clinical setting), and 3) accessibility (e.g. training in the
neighborhood and free access to fitness center) for both
children and their families. Our hypothesis was to find a de-
crease in BMI supported by a decrease in fat mass and an
increase in muscle mass (DXA-scans) in the intervention
group compared to the control group. Furthermore, we ex-
pected to find increased fitness and strength, improvement
in glucose and lipid metabolism, and profitable changes in
plasma levels of adipokines.Methods
Ethics statement
The parents and children were given both oral and
written information about the study and the parents signed
a consent form. The study was carried out in accordance
with the Helsinki declaration and approved in advance
(1 December 2011) by the Danish Ethics Committees of
the Capital Region (record number H-2-2011-132).
This study was registered at the Danish Data Protection
Agency (record number 2008-54-0474).
In addition, the study was registered at Clinicaltrials.
gov (Identifier number NCT01660789).
The authors confirm that all ongoing and related trials
for this intervention are registered.
Participants and procedures
Postal letters were sent to parents in Høje-Taastrup
Municipality near Copenhagen with children aged 7–10
years in regard to information from the ‘SundSkoleNettet’/
‘The Healthy Schools Network’ (SSN). SSN is a national
Danish network collecting yearly data on Danish public
school children’s health status (measurements include
weight, height, waist, jump height, aerobic fitness test, and
steps registered with pedometer), with the aim to monitor
the health of children. Parents with overweight children
(n = 867) were invited to participate in early evening infor-
mation meetings about the intervention program and the
tests at Rigshospitalet. All the potential participants attend-
ing the information meetings were screened for inclusion.
Inclusion criteria was overweight defined as a BMI
above the 90% percentile (thus also including obesity
which is defined as a BMI above the 99% percentile) on the
BMI curve (guidelines from the Danish Paediatric Society
on age- and gender specific BMI curves) [20] at inclusion
day. Subjects with an age below six and above 10 years,
physical or mental handicap, use of medicine within the last
three months, and somatic illness as cause for obesity were
excluded. After inclusion the children were gender and age-
stratified and block-randomized into an intervention or a
control group by the Rockwool Foundation Research unit.
All baseline measurements were performed within the
duration of four days, during the first week of January
2012. The subjects from the intervention group and the
control group were equally divided among these four days.
The follow up measurements were performed 20 weeks
after baseline (in mid June 2012). Each child was tested
during two days.
At both study days all the children obtained a medical
examination, as well as blood screen, and pubertal devel-
opmental stage was evaluated by breast stages (B1-B5)
in girls and by genital stages (G1-G5) in boys according
to Tanners criteria. Furthermore, testicular volume was
assessed by orchidometry, and a testicular volume above
3 mL was defined as the onset of puberty.
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measurements began 2 January 2012, the intervention
began 9 January 2012, and the follow up measurements
were completed 18 June 2012. All measurements were
carried out at the Centre of Inflammation and Metabolism,
Rigshospitalet, Denmark.
Intervention
The intervention was conducted by a private association,
and was initiated the week after baseline measurements.
The intervention consisted of a) 60 minutes weekly
group training session of the children at schools close to
the children’s residences, b) 90 minutes weekly group
training session of the children, their parents, and sib-
lings at a municipal fitness club, c) individual nutritional
guidance and coaching of the children and their families
(twice during the program), and d) common cooking and
dining with the children and their families (twice during
the program). The weekly training session for the children
alone began with a 15 minute talk about the past week and
the well-being of the children, followed by 45 minutes of
continual exercise, games, and dancing. The weekly training
session for the families began with 30 minutes of instruc-
tion on health topics, e.g. a healthy diet and the conse-
quences of overweight and physical inactivity. In the weekly
sessions for the children alone, the training was focused on
physical activity games, e.g. schoolyard games, whereas the
weekly session with the families comprised primarily aer-
obic and strength exercises. Although the program was not
based on any specific psychological strategies, the instruc-
tors continuously tried to give the children a positive and
successful experience while progressively increasing the in-
tensity of the physical activity and challenging the children’s
motor skills. The nutritional guidance followed ‘The Official
Dietary Guidelines’ by the Ministry of Food, Agriculture
and Fisheries (Danish Veterinary and Food Administration)
[21], and there were no caloric restrictions during the
intervention. The program was free of charge for the
families, as the program was fully paid for by funding,
and the training facilities were made available by the
Høje-Taastrup Municipality. The two instructors in the
program were a bachelor in Nutrition and Health and an
exercise instructor. After the follow up test days the con-
trol group entered the intervention program for 40 weeks.
Outcome measures
Anthropometry and blood pressure measurements
Weight was measured at baseline and follow up to the
nearest 0.1 kg on an electronic scale (Bisco scales, Farum,
Denmark), with the children dressed in underwear. Height
was measured to the nearest 0.5 cm using a portable
stadiometer (HR 001, Tanita Leicester Portable Height
Measure, Tokyo, Japan). Body mass index (BMI) was cal-
culated as weight (kg)/height2 (m2) and standardized BMI(zBMI) was calculated for international comparison using
the International Obesity Task Force (now also known as
World Obesity/ Policy & Prevention) BMI cut-off values for
thinness, overweight and obesity developed by Cole et al.
[22]. Waist and hip circumference were measured by the
same person at baseline and follow up to the nearest 0.5 cm
with a circumference measuring tape (Meterex, Langenfeld,
Germany). Waist circumference was defined as the midline
between the lowest border of rib cage and the upper border
of iliac crest, and hip circumference as the broadest level on
hips while the child was standing. The waist-height ratio
(WHtR) was calculated as waist (m)/height (m). The resting
blood pressure and heart rate were measured three times
with an automated oscillometric upper arm blood pressure
monitor (Omron 705IT, Omron Corporation, Kyoto, Japan),
and the mean of the last two measurements were used.
Arterial hypertension was defined according to the guide-
lines from the Danish Paediatric Society [23].
Body composition measured by DXA scan
The same person performed the scans on all children at
baseline and at follow up. Total and regional muscle and
fat mass were measured using a dual-energy X-ray absorpti-
ometry scanner (Lunar Prodigy Advance, GE Medical
systems, Lunar, Milwaukee, WI, USA).
Physical activity measurements
The children’s habitual physical activity was assessed by a
pedometer (Yamax Digi-walker CW-300 pedometer). The
pedometer was worn attached to the waistband during all
waking hours (except while bathing). A mean of the steps
registered on the least active single day (minimum) and a
mean of the steps registered on the most active single day
(maximum) were calculated for each of the two groups in
the two periods. To adjust for within-week variation in
physical activity the total mean steps for each child were
weighted with 5/7 and 2/7 for weekdays and weekend
days, respectively.
Cardiorespiratory fitness was assessed indirectly using
a modified Andersen fitness test [24]. In the modified
Sargent Jump Test (using a vertical jump mat from SSN
produced by Keld Jepsen, Denmark) the child was placed
with two feet on the mat with a belt connected to a
measuring tape grounded to the mat. The vertical jump
was performed with free movements of the upper limbs
and total freedom in joint flexion of the lower limbs.
The child was asked to jump straight up as high as possible
and land on both feet again, and the best result (in cm) of
three attempts was recorded.
The standardized oral glucose tolerance test and the
continuous glucose monitoring system
The children were asked to monitor their diet the day be-
fore the baseline study days, and subsequently eat exactly
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a 10 hour overnight fast the children were transported
to the laboratory. EMLA patches (AstraZeneca, London,
England) were applied for approximately 30 minutes prior
to peripheral catheter insertion, and the Continuous Glu-
cose Monitoring System (CGMS) sensor placement. A
small, peripheral catheter was placed in an antecubital vein
for blood sampling. An oral glucose load was administered
(1.75 g/kg, maximum of 75 g in 300 ml water flavored
with lemon juice). Baseline screening samples were
drawn at time point 0, and blood samples (glucose and
insulin) were drawn every 30 minutes for two hours. Blood
samples were collected in EDTA-containing tubes and im-
mediately centrifuged for 15 minutes at 3,500 rpm, and
the plasma was stored at −80°C until further analysis.
Pre-diabetes and diabetes cut-off values were defined
by the International Society for Pediatric and Adolescent
Diabetes [25]. HOMA-IR was calculated as fasting insulin
concentration (μU/mL) X fasting glucose concentration
(mmol/L)/ 22.5 [26,27]. MATSUDA insulin sensitivity index
was calculated as [28]:
Matsuda index ¼ 10; 000=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
½ðfasting plasma insulin
 fasting plasma glucoseÞ
 ðmean plasma glucose
concentration during OGTT
 mean plasma insulin
concentration during OGTTÞ:
vuuuuuuuuut
The CGMS consisted of two systems: 1) The iPro2 re-
corder (Medtronic Diabetes Inc, Northridge, USA) and 2)
The Guardian REAL-time CGM (Medtronic Diabetes Inc,
Northridge, USA), using the same glucose sensor (Enlite
Glucose Sensor, Medtronic Diabetes Inc, Northridge,
USA). The glucose sensor was inserted just under the skin
of the lower part of the abdomen. The child (or their par-
ents) measured a calibrating blood sugar one hour after
insertion, and subsequently four times a day in five days
using a blood sugar apparatus (Contour, Bayer Health-
Care). Data from two consecutive days were used for
analyses.
Biochemical assays
The circulating levels of plasma insulin, plasma c-peptide,
plasma glucose, plasma cholesterols, plasma triglycerides,
plasma alanintransaminase (ALAT), plasma aspartattran-
saminase (ASAT), plasma thyroid hormones, hemoglobin
in blood, and glycosylated hemoglobin (HbA1c) in blood
were measured using standard techniques at the
Department of Clinical Biochemistry, Rigshospitalet
University Hospital, Copenhagen, Denmark. Plasma leptin
and plasma adiponectin levels were measured using Meso
Scale Discovery (MSD) electrochemiluminescence (Meso
Scale Discovery, Gaithersburg, MD, USA). Serum resistin
and serum visfatin levels were measured using high-sensitivity ELISA (human resistin # DRSN00, R & D
Systems, Minneapolis, MN, USA, and human visfatin #
K4907-100, BioVision, Mountain View, CA, USA). All
samples were run in duplicates and the means were cal-
culated. The intra-assay coefficients of variation (CV)
were less than 20% for leptin, adiponectin, resistin, and
visfatin according to the manufacturer. Levels of serum
Follicle-stimulating hormone (FSH), Luteinizing hormone
(LH), testosterone, estradiol, sex hormone-binding globu-
lin (SHBG) [29,30], IGF-I, and Insulin-like growth factor-
binding protein 3 (IGFBP-3) [31,32] were measured as
previously described with validated methods using estab-
lished pediatric reference ranges.
Statistical analyses
Analysis on the primary outcome (BMI) was performed
according to the intention-to-treat principle. All secondary
analyses were performed as ‘complete-case-analyses’. As
data was missing on two subjects, data was imputed (using
the Stata command ‘mi impute’) on the primary outcome.
Differences between the study groups at baseline were
assessed by the student’s t-test or Wilcoxon’s rank-sum
test, when appropriate. Intervention effects were analyzed
using analyses of co-variance (ANCOVA). Analysis
on the primary outcome (including the imputed data)
was furthermore adjusted for missing data uncertainty
(using the Stata command ‘mi estimate’). The inter-
vention effect (abbreviated as DELTA in the text) was
defined as the difference in changes between the group’s
outcome variables adjusted for the respective baseline
values. The analyses were adjusted for their respective
baseline values in order to comply with potential regres-
sion towards the mean [33]. Standard regression diag-
nostics were performed, and significance was accepted as
P <0.05 (two-tailed). Secondary outcomes are regarded as
explorative and are thus not corrected for multiple testing.




Of the 39 children who came to the early evening infor-
mation meetings, one child was excluded because of
normal BMI, and 38 children fulfilled the inclusion cri-
teria and were hence included in the study; 19 were allo-
cated to the intervention group and 19 to the control
group. The overall study design is depicted in Figure 1
(CONSORT 2010 Flow Diagram [34]).
Before baseline measurements (see Figure 1) one child
dropped out (n = 37 children at Baseline). Blood sam-
ples were only drawn in 30 of the 37 children at base-
line, and due to logistical reasons the oral glucose
tolerance test (OGTT) was only applied to a subsample
of children (n = 26), and the CGMS on 20 children (one
Figure 1 Design of the randomized controlled trial. CONSORT 2010 Flow Diagram [34] showing the number of children invited, enrolled,
allocated, at Follow-Up, and in the analyses. *Children (age 7–10 years) at inclusion time in Høje Taastrup Municipality who were identified as
overweight or obese by the ‘SundSkoleNettet’/‘The Healthy Schools Network’. **Children (age 7–10 years) at inclusion time who participated in
the early evening information meetings.
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data at baseline and three children excluded from ana-
lyses because of lack of sufficient sensor data at follow
up). The anthropometric data from two children were
lost, and the body weight is replaced with the weight
from the DXA scans at baseline and follow up (one of
these children was a drop-out at follow up). Six children
were excluded from pedometer measurements because
of illness or lack of data at baseline and further three in
the analyses for the same reasons at follow up. Three
children were excluded from analyses of the fitness test
because of crying, walking or falling during the test, and
one child from the jumping test because of lack of par-
ticipation. None of these children deviated from the restof the group in measurements of BMI and whole body
dual-energy X-ray absorptiometry (DXA) scan.
The adherence (mean percentage of attended sessions)
to the intervention program was 74 ± 17% (mean ± SD).
Baseline assessment
At baseline the 37 children had a mean age of 8.7 ±
0.9 years and a BMI of 21.8 ± 3.7 kg/m2. There were no
significant differences between the control and inter-
vention group on any of the descriptive baseline mea-
surements (Table 1), and only in two of the explorative
measurements (Table 2). The children had individually
normal medical examinations and blood screens at
baseline.
Table 1 Descriptive characteristics of the children at baseline
Control group Intervention group P value
n Baseline Baseline
Girls (total and percentage) 37 15 (83.3) 15 (78.9) -
Age (years) 37 8.7 (0.9) 8.8 (0.9) 0.8
Birth weight (gram) 35 3,634 (488.4) 3,555 (417.0) 0.6
Body composition
Weight (kg) 37 39.7 (8.1) 44.6 (10.1) 0.1
BMI (kg/m2) 37 21.0 (3.5) 22.6 (3.8) 0.2
Overweight (total and percentage) 20 12 (67) 8 (42) 0.3
Obese (total and percentage) 17 6 (33) 11 (58) 0.1
zBMI 37 1.8 (0.8) 2.2 (0.8) 0.1
Waist (cm) 35 79.2 (7.4) 81.2 (8.9) 0.5
Hip (cm) 35 80.7 (8.7) 84.1 (8.2) 0.2
Waist-to-height ratio 35 0.6 (0.1) 0.6 (0.1) 0.9
DXA scan 37
Lean body mass (kg) 23.1 (3.3) 25.3 (4.3) 0.1
Fat mass (kg) 15.0 (5.4) 17.6 (6.8) 0.2
Body fat tissue percent (%) 38.3 (7.1) 40.2 (7.0) 0.4
Android fat mass (kg) 1.3 (0.5) 1.7 (0.8) 0.08
Gynoid fat mass (kg) 2.9 (1.0) 3.4 (1.2) 0.2
Android/gynoid ratio 0.4 (0.1) 0.5 (0.1) 0.05
Blood Pressure and pulse 37
Systolic (mmHg) 101.9 (8.0) 102.2 (8.9) 0.9
Diastolic (mmHg) 62.8 (7.7) 62.0 (6.1) 0.6
Heart Rate (beats/min) 81.4 (13.6) 79.7 (11.0) 0.7
Fitness
Steps per day (maximum) 31 14,313 (3,176) 13,049 (2,783) 0.3
Modified Andersen fitness test (meter) 37 689.6 (135.5) 649.5 (173.9) 0.4
Jumping test (cm) 37 22.9 (4.3) 24.6 (6.3) 0.4
Presented as mean (standard deviation) or total in the group (percentage of the group).
P value assessed by unpaired Student’s t-test.
zBMI, standardized BMI.
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The anthropometric data of the children at baseline is
presented in Table 1. There was a decrease in total body
weight and in BMI in the intervention group compared
to the control group (Table 3). This included a signifi-
cant increase of BMI points within the control group
during the same period (Table 3). Waist, hip and WHtR
measurements decreased in both groups, with a larger
decrease in the intervention group compared to the con-
trol group (Table 3). One intervention child had arterial
hypertension at baseline, and two control children and
two intervention children were hypertensive at follow
up. There were no significant changes in either blood
pressure measurements or resting heart rate within or
between the two groups from baseline to follow up
(Table 3).Body composition measured by DXA scan
While the intervention group significantly lost fat mass,
the control group gained fat mass, from baseline to fol-
low up (Table 3). Furthermore, there was a significant
decrease in android and gynoid fat mass for the inter-
vention group compared to the control group from
baseline to follow up measurements (Table 3).
The glucose metabolism
None of the children were diabetic according to the
standardized OGTT performed (Table 2). Three chil-
dren were pre-diabetic (one control child at baseline,
and two from the control group and one from the inter-
vention group at follow up). There was a decrease in
the area under curve (AUC) from baseline to follow up
for plasma insulin, DELTA = −12,371 pmol/L*minutes
Table 2 Descriptive characteristics of the explorative measurements at baseline
Control group Intervention group P value
n Baseline Baseline
Glycemic control
HbA1c (mmol/mol) 30 34.9 (2.8) 34.9 (2.5) 1.0
Oral glucose tolerance test
Fasting glucose (mmol/L) 30 4.3 (0.2) 4.4 (0.3) 0.2
Fasting insulin (mmol/L) 30 62.9 (38.5) 67.7 (25.4) 0.7
120 min (2 h) glucose (mmol/L) 26 5.7 (1.1) 5.6 (0.8) 0.8
Matsuda Index 25 21.8 (12.4) 13.0 (3.9) P <0.05
HOMA-IR 30 1.7 (1.1) 1.9 (0.7) 0.6
Mean 48 h BG (mmol/L) by CGMS 19 4.8 (0.4) 5.3 (0.6) P <0.05
Biochemistry
Alanintransaminase (U/l) 29 30.1 (21.2) 26.8 (11.1) 0.6
Aspartattransaminase (U/l) 29 33.0 (12.2) 31.4 (5.2) 0.7
Thyrotropin (x10−3int.enh./l) 30 2.6 (1.2) 2.7 (0.9) 0.6
Triiodthyronin (nmol/l) 30 2.8 (0.5) 2.6 (0.3) 0.3
Thyroxin (nmol/l) 30 107.1 (26.8) 102.1 (18.9) 0.6
Total cholesterol (mmol/L) 30 4.6 (0.6) 4.3 (0.9) 0.5
LDL (mmol/L) 30 2.7 (0.4) 2.7 (0.8) 0.9
HDL (mmol/L) 30 1.5 (0.4) 1.4 (0.4) 0.5
Triglycerides (mmol/L) 30 0.9 (0.8) 0.7 (0.2) 0.4
Estradiol (pmol/L)# 29 35 (30) 28 (14) 0.05
Testosterone (nmol/L)# 28 0.12 (0.0) 0.12 (0.0) 0.9
Sex hormone-binding globulin (nmol/L)# 29 62 (37) 49 (33) 0.4
Follicle-stimulating hormone (IU/L)# 29 1.11 (1.33) 1.06 (0.81) 0.9
Luteinizing hormone (IU/L)# 29 0.03 (0.12) 0.03 (0.04) 0.4
IGFBP-3 (ng/mL)# 29 4080 (1130) 4695 (490) 0.06
Insulin-like growth factor 1 (ng/mL)# 29 229 (131) 244.5 (74) 0.6
Adiponectin (ng/mL)# 26 19,547 (8,790) 18,138 (5,740) 0.5
Leptin (pg/mL)# 25 17,613 (27,432) 26,399 (23,333) 0.3
Resistin (ng/mL)# 26 7.0 (2.5) 7.5 (2.1) 0.3
Visfatin (ng/mL)# 23 0.34 (0.49) 0.39 (0.62) 0.9
Presented as mean (standard deviation) and P value assessed by unpaired Student’s t-test, or #median (interquartile range) and P value assessed by Wilcoxon
rank-sum test.
Mean 48 h BG by CGMS, mean blood glucose measured in 48 h by continuous glucose monitoring system.
HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
IGFBP-3, Insulin-like growth factor-binding protein 3.
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plasma C peptide, DELTA = −48,263 pmol/L*minutes
(95% CI:-84,068; −12,459, P = 0.01, data not shown)
during the OGTT in the intervention group compared
to the control group with no difference in AUC plasma
glucose (Figure 2B). Furthermore, there was an increase
in the MATSUDA Index for insulin sensitivity at follow
up in the intervention group compared to the control
group (Table 4). There were no differences between the
groups in regard to DELTA values of the fasting plasmalevels of glucose, insulin, HbA1c or HOMA-IR (Table 4).
Furthermore, there were no differences between the
two groups in the glucose measurements during the
CGMS (Table 4).
Physical performance
There was an increase in weighted mean steps per day
in both groups (P = 0.05 within the control group), but a
significantly higher increase in the intervention group,
with DELTA = 2,617 steps per day (95% CI: 202; 5,032,
Table 3 Delta changes in descriptive variables from baseline to follow up time point
n Control Δadj n Intervention Δadj n Intervention effect Δadj P value
Body composition
Weight (kg) intention-to-treat 18 1.9 (1.7; 2.1) 19 −1.9 (−2.1; −1.6) 37 −4.0 (−4.9; −3.0) P <0.001
BMI (kg/m2) intention-to-treat 18 0.3 (0.3; 0.4) 19 −1.6 (−1.7; −1.5) 37 −2.0 (−2.5; −1.5) P <0.001
zBMI intention-to-treat 18 0.07 (0.05; 0.08) 19 −0.43 (−0.44; −0.42) 37 −0.5 (−0.6; −0.4) P <0.001
Weight (kg) 18 2.0 (1.4; 2.7) 18 −2.0 (−2.6; −1.3) 36 −4.0 (−4.9; −3.0) P <0.001
BMI (kg/m2) 17 0.4 (0.0; 0.7) 18 −1.6 (−2.0; −1.3) 35 −2.0 (−2.5; −1.5) P <0.001
zBMI 17 −0.07 (−0.2; 0.2) 18 −0.44 (−0.5; −0.3) 35 −0.5 (−0.6; −0.4) P <0.001
Waist (cm) 17 −0.5 (−2.0; 0.9) 18 −5.3 (−6.7; −3.9) 35 −4.8 (−6.8; −2.8) P <0.001
Hip (cm) 17 −0.7 (−2.1; 0.6) 18 −5.3 (−6.6; −4.0) 35 −4.5 (−6.4; −2.6) P <0.001
Waist-to-height ratio 17 −0.01 (−0.02; 0.00) 18 −0.05 (−0.06; −0.04) 35 −0.03 (−0.05; −0.02) P <0.001
DXA scan 18 18 36
Lean body mass (g) 1,806 (1,352; 2,260) 1,043 (584; 1,501) −763 (−1,426; −101,1) P <0.05
Fat mass (g) 711 (185; 1,238) −2,733 (−3,261; −2,205) −3,344 (−4,200; −2,689) P <0.001
Body fat tissue percent (%) −0.4 (−1.5; 0.7) −5.3 (−6.4; −4.2) −4.9 (−6.5; −3.3) P <0.001
Android fat mass (g) 53.8 (−33.8; 141.5) −324.5 (−411.0; −237.9) −378.3 (−503.6; −253.0) P <0.001
Gynoid fat mass (g) 121.2 (5.0; 237.5) −446.4 (−561.4; −331.5) −567.7 (−732.8; −402.5) P <0.001
Android/gynoid ratio 0.005 (−0.01; 0.02) −0.044 (−0.06; −0.02) −0.049 (−0.08; −0.02) P <0.001
Blood Pressure and pulse 18 18 36
Systolic (mmHg) 0.4 (−4.1; 5.0) 2.3 (−2.2; 6.9) 1.9 (−4.5; 8.4) 0.6
Diastolic (mmHg) −0.2 (−5.1; 4.7) −1.1 (−6.0; 3.7) −0.9 (−7.8; 6.0) 0.8
Heart Rate (beats/min) 1.5 (−2.8; 5.8) −4.2 (−8.5; 0.1) −5.7 (−11.8; 0.4) 0.07
Fitness
Steps per day (maximum) 14 2,760 (408; 5,111) 13 4,705 (2,314; 7,096) 27 1,946 (−1,140; 5,331) 0.3
Modified Andersen fitness test (meter) 17 62.3 (26.4; 98.3) 16 92.3 (55.3; 129.3) 33 30.0 (−22.0; 81.8) 0.3
Jumping test (cm) 18 1.9 (−0.3; 4.1) 17 4.0 (1.8; 6.2) 35 2.1 (−1.1; 5.2) 0.2
P values are representing the intervention effects (the difference in change between the groups) adjusted for the respective baseline values (95% confidence
intervals).
P values assessed by ANCOVA.
zBMI, standardized BMI.
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the mean number of minimum steps per day in the
intervention group, DELTA = 3,991 minimum steps/day
(95% CI: 1,162; 6,820, P = 0.008, Figure 3) whereas there
was no difference between groups with regard to mean
maximum steps per day (Table 3). Both group enhanced
performance from baseline to follow up with regard to
the modified Andersen fitness test and the modified
Sargent vertical jump test.
There were no significant differences at follow up in
enhanced performance between the two groups in the
two tests (Table 3).
Pubertal stages
The children in both groups were equally pre-pubertal/
pubertal at baseline (intervention group = 3 and control
group = 4) and there was no indication of the interven-
tion delaying the pubertal development.Biochemistry
There were no significant differences between the two
groups at follow up with regard to hemoglobin (data not
shown) in blood, plasma ALAT, plasma ASAT, plasma
thyroid hormones, and plasma lipid levels (Table 4).
There was an increase in plasma levels of adiponectin in
the intervention group compared to the control group at
follow up (Table 4). A larger increase in SHBG was found
in follow up measurements in the intervention group com-
pared to the control group (Table 4). There were no sig-
nificant DELTA differences between the two groups in
plasma levels from baseline to follow up of serum resistin,
plasma leptin, and serum visfatin (Table 4).
Discussion
Findings from this trial indicate that a relatively low in-
tensive multicomponent intervention can induce large
and clinically important decreases in BMI and other
Figure 2 (See legend on next page.)
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(See figure on previous page.)
Figure 2 The glucose metabolism measured by oral glucose tolerance test. The area under curve is shown as bar graphs, while the
response over time is shown as curves for plasma insulin (A) and glucose (B), respectively. P values are representing the intervention effects (the
difference in change between the groups) adjusted for the respective baseline values (95% confidence intervals as error bars on bar graphs and
Standard Error of the Mean as error bars on curves). ★, P <0.05; NS, not significant.
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overweight children. In addition, this intervention induces
changes in metabolic risk factors, involved in the patho-
genesis of type 2 diabetes. Furthermore, the intervention
seemed to increase the physical activity level among the
intervention group by increasing their basal physicalTable 4 Delta changes in the explorative measurements from
n Control Δadj
Glycemic control
HbA1c (mmol/mol) 12 −0.3 (−0.8; 0.1) 1
Oral glucose tolerance test
Fasting glucose (mmol/L) 14 0.1 (−0.1;0.3) 1
Fasting insulin (mmol/L) 13 −4.7 (−17.6; 8.2) 1
120 min (2 h) glucose (mmol/L) 10 0.6 (−0.1; 1.3) 1
Matsuda Index 9 −3.4 (−10.2; 3.5) 1
HOMA-IR 13 0.1 (−0.5; 0.3) 1
Mean 48 h BG (mmol/L) by CGMS 7 0.1 (−0.6; 0.9)
Biochemistry
Alanintransaminase (U/l) 12 −7.9 (−12.6; −3.3) 1
Aspartattransaminase (U/l) 12 −2.0 (−5.1; 1.1) 1
Thyrotropin (x10−3int.enh./l) 14 0.1 (−0.4; 0.6) 1
Triiodthyronin (nmol/l) 14 −0.2 (−0.3; 0.0) 1
Thyroxin (nmol/l) 14 0.8 (−3.9; 5.5) 1
Total cholesterol (mmol/L) 14 −0.3 (−0.5; 0.0) 1
LDL (mmol/L) 14 −0.1 (−0.3; 0.1) 1
HDL (mmol/L) 14 0.1 (0.0; 0.1) 1
Triglycerides (mmol/L) 14 −0.1 (−0.2; 0.0) 1
Estradiol (pmol/L) 13 −11.8 (−22.4; −1.2) 1
Testosterone (nmol/L) 12 0.0 (0.0; 0.1) 1
Sex hormone-binding globulin (nmol/L) 13 4.2 (−2.4; 10.8) 1
Follicle-stimulating hormone (IU/L) 13 0.1 (−0.2; 0.3) 1
Luteinizing hormone (IU/L) 13 0.0 (−0.1; 0.3) 1
IGFBP-3 (ng/mL) 13 −73.2 (−233.5; 87.0) 1
Insulin-like growth factor 1 (ng/mL) 13 49.8 (15.1; 84.5) 1
Adiponectin (ng/mL) 12 −1,693 (−3,143; −242) 1
Leptin (pg/mL) 11 −7,803 (−15,402; −205) 1
Resistin (ng/mL) 12 −0.4 (−0.9; 0.1) 1
Visfatin (ng/mL) 10 0.0 (−0.3; 0.2) 1
P values are representing the intervention effects (the difference in change between th
P values assessed by ANCOVA.
Mean 48 h BG (mmol/L) by CGMS, mean blood glucose measured in 48 h by contin
HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipactivity level (minimum number of steps/day). Thus,
the present study adds important knowledge to the
existing evidence of the effect from different interven-
tions for overweight and obese children [17,18,35,36].
Overweight and obesity are most commonly defined
by age- and gender specific BMI percentiles in childrenbaseline to follow up time point
n Intervention Δadj n Intervention effect Δadj P value
4 −0.5 (−0.9; −0.1) 26 −0.2 (−0.8; 0.5) 0.6
4 0.1 (−0.1; 0.2) 28 0.0 (−0.3; 0.3) 0.4
2 −13.4 (−26.7; −0.1) 25 −8.7 (−27.4; 10.0) 0.3
3 0.1 (−0.5; 0.7) 23 −0.5 (−1.4; 0.4) 0.3
2 7.4 (1.9; 13.0) 21 10.8 (1.4; 20.2) P <0.03
2 −0.4 (−0.8; 0.1) 25 −0.3 (−0.9; 0.3) 0.3
9 −0.3 (−1.0; 0.4) 16 −0.4 (−1.5; 0.7) 0.4
4 −9.1 (−13.3; −4.8) 26 −1.1 (−7.4; 5.2) 0.7
4 −2.9 (−5.8; 0.0) 26 −0.9 (−5.1; 3.3) 0.7
4 0.3 (−0.1; 0.8) 28 0.2 (−0.5; 0.9) 0.5
4 −0.2 (−0.4; −0.1) 28 −0.1 (−0.3; 0.1) 0.5
4 −0.6 (−5.3; 4.1) 28 −1.4 (−8.0; 5.3) 0.7
4 −0.5 (−0.8; −0.3) 28 −0.3 (−0.6; 0.0) 0.07
4 −0.4 (−0.6; −0.2) 28 −0.3 (−0.6; 0.0) 0.06
4 0.0 (−0.1; 0.1) 28 −0.1 (−0.2; 0.1) 0.4
4 −0.3 (−0.4; −0.1) 28 −0.2 (−0.3; 0.0) 0.1
3 −14.8 (−25.5; −4.1) 26 −3.0 (−18.6; 12.5) 0.7
3 0.0 (0.0; 0.1) 25 0.00 (−0.1; 0.1) 1
3 17.0 (10.5; 23.5) 26 12.9 (3.5; 22.3) P <0.01
3 0.0 (−0.3; 0.2) 26 −0.1 (−0.4; 0.3) 0.7
3 0.0 (−0.2; 0.2) 26 −0.1 (−0.3; 0.2) 0.5
3 −124.5 (−291.0; 42.0) 26 −51.3 (−293.0; 190.4) 0.7
3 4.4 (−30.2; 39.1) 26 −45.4 (−94.5; 3.8) 0.07
3 595 (−801; 1,990) 25 2,287 (254; 4,320) P <0.05
4 −14,374 (−21,069; −7,679) 25 −6,570 (−16,944; 3,803) 0.2
4 −0.6 (−1.0; −0.1) 26 −0.2 (−0.8; 0.5) 0.6
1 0.2 (−0.1; 0.4) 21 0.2 (−0.2; 0.5) 0.3
e groups) adjusted for the respective baseline values (95% confidence intervals).
uous glucose monitoring system.
oprotein; IGFBP-3, Insulin-like growth factor-binding protein 3.
Figure 3 Physical activity measured by pedometer. Weighted
mean steps per day (A) and mean minimum steps registered on the
least active single day (B) registered by Pedometer. P values are
representing the intervention effects (the difference in change
between the groups) adjusted for the respective baseline values
(95% Confidence intervals as error bars). ★, P <0.05; ★★, P <0.01.
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is a better predictor for type 2 diabetes than BMI
[12,37]. Central (visceral) fat is greatly associated with
cardiovascular diseases and type 2 diabetes [38]. Both
physical inactivity and visceral fat are associated with
chronic low-grade inflammation [2], and it has been
shown that chronic inflammation contributes to the de-
velopment of e.g. insulin resistance, atherosclerosis and
tumor growth [2]. The amount of visceral fat is associ-
ated with obesity in children [39] as well as inactivity
and high caloric intake in adults [9,40]. WHtR in chil-
dren and waist-to-hip-ratio in adults correlates with cen-
tral (visceral) obesity [41] and has been shown to be
more accurate than BMI in predicting cardiometabolic
risk factors in both children and adults [42-44]. In the
present study there was a significant decrease in WHtR,
and thereby in central obesity, in the intervention group,
indicating an important risk reduction with regard to
cardiometabolic diseases within these children. The chil-
dren in the present study had normal glucose metabo-
lism at baseline and at follow up (normal fasting glucose,
fasting insulin, and two hours glucose values during
OGTT). There was however a significant decrease ininsulin AUC during the OGTT and a significant increase
in the MATSUDA insulin sensitivity index in the inter-
vention group compared to the control group, indicating
an improvement of the children’s peripheral insulin sen-
sitivity, i.e. improvement of the peripheral utilization of
glucose, which is consistent with the present finding of
improved WHtR and android fat mass (i.e. less visceral
fat). Interestingly, there was a significant increase in the
SHBG levels of the intervention children at follow up,
which also support the findings in this study of an im-
provement in insulin sensitivity and decrease in meta-
bolic risk, as earlier shown in adults [45] and in children
and adolescents [46,47].
An increase in the intervention group was also ob-
served with regard to the mean number of steps per day
as well as in the mean number of minimum steps taken
per day. These data indicate an increase in physical ac-
tivity of the children, supporting the findings of im-
proved peripheral insulin sensitivity and less visceral fat
mass [9,40].
All children (n = 36) improved cardiorespiratory fitness
(within group; control group with 8.2% and intervention
group with 18.5%) and leg strength (within group; control
group with 9.4% and intervention group with 15.4%), and,
supported by other studies, there was no significant im-
provement in the intervention group compared to the
control group at follow up [35,48]. Previous studies have
found elevated blood pressure levels in approximately 35%
of overweight and obese European children [49]. Only one
of the 37 children (2.7%) in the present study had arterial
hypertension at baseline, and there was no significant de-
crease in arterial blood pressure in the intervention group
compared to the control group after the intervention. One
explanation could be that in pre-pubertal children this
diagnosis is missed in 55% of casual measurements com-
pared to 24 hour blood pressure measurement [37].
Another explanation could be that the children in the
present study were primarily overweight rather than
obese.
The hypothesis of the present study was that the
explorative measurements would support the beneficial
effects of weight loss and increased physical activity as
previously found in adults and children [36,50-52]. The
present study could not reproduce findings such as a re-
duction in blood lipids, blood pressure or glycosylated
hemoglobin, as the reductions were found in both
groups in these variables. A lack of change in the latter
parameters may simply be ascribed to the fact that these
metabolic and physiologic parameters were normal at
baseline. Thus, although the children were overweight,
their metabolism was not severely disturbed. Knowing
that adipose tissue also serves as a large endocrine organ
that secretes hormones, cytokines and proteins [53], and
that weight loss is associated with a reduction in the
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looked at different biomarkers that may predict diabetic
risk in children [54]. Low plasma levels of the adipokine,
adiponectin, have been shown to correlate with in-
creased risk of insulin resistance in children [51,54], and
there was an increase in the intervention group com-
pared to the control group (who had a significant de-
crease within the group). For both of the adipokines;
serum resistin and plasma leptin (markers of insulin re-
sistance [43,54]), there was a significant decrease within
the intervention group, but this was not significant com-
pared to the control group, where there also was a
(non-significant) decrease. Serum levels of the adipokine
visfatin (which decreases with exercise training [52]) did
not change within the two groups.
Strengths and limitations
The strength of the study is the low intervention expos-
ure (only twice-a-week training sessions), accessibility,
and the low drop-out rate. Only two children (<6%)
dropped out of the study of whom one child dropped
out before the baseline measurements. This indicates
that the approach described in this paper is highly fea-
sible. Additional strengths include the high internal vali-
dity of the outcome variables.
A possible methodological weakness of the study could
be a self-selection bias, as the families had to show up to
the information meetings before selection to the study.
This would limit the generalizability of our findings. Fur-
thermore, as this was a convenience sample, no formal
power calculation was performed to determine the sam-
ple size, thus increasing the risk of under powering our
study. However, with the given sample size and variation
in the primary outcome, we are able to detect a between
group difference of 1.84 in BMI across the study period.
Other possible limitations are that the follow up mea-
surements were taken 20 weeks after the beginning of
the 40-week intervention, and there is no information of
the long-term outcome and possible health benefits of
this intervention. It should be pointed out, though, that
the intervention program is working with the local Mu-
nicipalities and the school nurses, and, that this was the
first time the intervention was systematically evaluated.
The present results may help with the future accessibility
of the intervention.
Combined, the explorative data showed positive effects
in the intervention group, however, when the control
group was taken into account, the observed intervention
effects were not always statistically significant. Thus, for
many parameters the control group demonstrated slight
positive effects. Reasonable explanations for this trend
could be that the explorative analyses were underpowered
and due to common factors such as maturation and prac-
tice. In addition, the length of the intervention (20 weeksout of 40 weeks intervention) or seasonal variation (base-
line was just after the mandatory Christmas school holiday)
could explain this tendency. Furthermore, one could argue
for a positive effect on the control children might be that
they were selected for, and had chosen to attend, the inter-
vention after the study measurements. Hence, the con-
trol children were motivated for a lifestyle change
already at baseline. Most of the children in this study
were girls (30 out of 37), which could bias the effect as to
biological gender differences in fitness and fat mass and
limit generalizability to the general overweight population.
Gender effects were not found in adjusted analysis, but as
the study wasn’t powered to stratify by gender this observa-
tion should be interpreted with caution (data not shown).
It would be highly relevant to repeat the intervention
in a larger scale where focus is on generalizability,
cost-effectiveness, and the long-term outcomes of the
intervention.
Conclusions
The present study demonstrates a feasible multi-
component intervention with physical activity, diet coun-
seling and family coaching of overweight and obese
children in urban public schools at the age of 7–10 years.
Twenty weeks of this low-cost, twice-a-week training ses-
sion intervention, that included the families’ participation,
reduced the children’s BMI, and more importantly, WHtR,
fat mass, fat distribution, and increased their physical
activity (by increasing their minimum steps per day). In
addition, this study shows that physical activity and diet
counseling have the same beneficial effects in children on
the elements of the metabolic syndrome as shown in
adults [55,56], including an increase in the peripheral in-
sulin sensitivity, bringing these children closer to adopting
a healthier lifestyle.
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